BullScope
  • Home
  • Market News
  • Bargains & Bubbles
  • Expectations Audits
  • Research Notes
  • Said vs. Filed
  • The Economy
  • Evidence Sheets
  • Research Terminal
No Result
View All Result
SUBSCRIBE
BullScope
  • Home
  • Market News
  • Bargains & Bubbles
  • Expectations Audits
  • Research Notes
  • Said vs. Filed
  • The Economy
  • Evidence Sheets
  • Research Terminal
No Result
View All Result
BullScope
No Result
View All Result
Home Market News

Amazon’s operating margin hits record 13.9% as AWS growth accelerates to 39%

Moe Alsumidaie by Moe Alsumidaie
October 30, 2026
in Market News
0
74
SHARES
1.2k
VIEWS
Share on XShare on LinkedInShare on Facebook

Amazon’s operating margin reached 13.9% in the third quarter, its highest ever, as AWS revenue growth accelerated to 39% year-over-year, the fastest pace in nearly five years. Operating income nearly doubled to $28.1 billion from $17.4 billion in the same quarter last year, driven by margin expansion across all three business segments and a sharp deceleration in retail growth that masks underlying operational improvement.

Total net sales rose 12% to $201.9 billion, or 13% excluding a $0.9 billion foreign exchange headwind. The company noted that Prime Day timing shifted to Q2 this year from Q3 last year, which suppressed the reported quarter by approximately 400 basis points of growth. North America segment sales increased 6% to $112.9 billion, while International rose 5% to $43.1 billion (8% excluding currency effects). AWS segment sales reached $46.0 billion, putting the business on a $184 billion annualized revenue run rate.

Operating income gains were steeper than revenue gains. North America operating income jumped to $8.7 billion from $4.8 billion year-over-year, while AWS operating income rose to $17.8 billion from $11.4 billion. International operating income increased to $1.6 billion from $1.2 billion. Net income fell to $20.7 billion, or $1.89 per diluted share, from $21.2 billion or $1.95 per share, primarily because the prior-year quarter included $9.5 billion in pre-tax gains from Anthropic investments.

The company provided forward guidance in CEO Andy Jassy’s statement, projecting AWS revenue growth rates exceeding 40% in both 2027 and 2028. This represents a modest deceleration from the 39% growth achieved in Q3, suggesting the company expects the current pace to persist rather than accelerate further.

BullScope TerminalYou just read AMAZON COM INC’s filed numbers.Every claim above traces to a filing. Run any of 500+ companies through the same math-vs-mood engine. Free tier available.Open the Terminal →

What it means

The margin expansion is real and operational. AWS operating income grew 56% while its revenue grew 39%, indicating the segment is converting incremental sales to profit at a faster rate than top-line growth, a sign of operating leverage as infrastructure investments mature and customer deployments scale. North America operating income nearly doubled while sales grew only 6%, pointing to margin recovery in retail after years of investment in logistics and fulfillment. The company is capturing more of each dollar sold as it optimizes cost structure.

The retail growth deceleration is partly optical. Stripping out the Prime Day timing shift, underlying Q3 retail growth would have been roughly 10%, closer to the company’s historical trajectory. AWS is the true growth engine now, and its 39% expansion, the fastest in nearly five years, suggests the AI infrastructure cycle is accelerating. The company’s emphasis on Bedrock, AgentCore, and custom chips like Trainium indicates AWS is moving beyond compute commoditization into higher-margin managed services and purpose-built hardware.

Capital intensity remains the open question. Free cash flow swung to a $42.4 billion outflow for the trailing twelve months, from a $14.8 billion inflow a year prior, driven by a $94.8 billion year-over-year increase in property and equipment purchases tied to AI infrastructure. The company has not quantified how much of this spending is AWS-specific versus retail fulfillment, nor when it expects returns on this capital to stabilize margins further. If AWS growth sustains above 40% while capital intensity peaks, margin expansion could accelerate; if capital spending persists at current levels without corresponding AWS growth acceleration, margins could compress.

What to watch

AWS guidance for 2027 and 2028 will be tested in the Q4 2026 earnings report (expected early 2027), where the company will report full-year results and provide updated forward guidance. The key metric is whether AWS growth remains in the 39-40% range or accelerates further, and whether the company signals a peak in AI infrastructure spending or commits to sustained elevated capex.

Source: the company’s 8-K filed 2026-10-29 with the SEC.

BullScope publishes impersonal research for a general audience. Nothing here is personalized investment advice, and nothing here is a recommendation to buy or sell any security. As of publication, neither BullScope nor its operator holds a position in any security, covered or otherwise; we do not trade at all, and we accept no compensation from any company we cover. When a conflict of interest exists, we do not publish: companies that compensate our operator in any capacity, or about which our operator could hold nonpublic information, are barred from coverage automatically, as described in the conflicts policy in our methodology. Figures come from company filings and public data through our published methodology; forecasts are conditional scenarios, not predictions and not promises. Markets carry risk, including loss of principal. Consider your own situation, or consult a licensed adviser, before acting on anything you read.

For the standing yardsticks on Amazon: the price tag, the filed record, and the four gauges, refreshed with each edition, see the BullScope Evidence Sheet: Amazon.

BullScope TerminalYou just read AMAZON COM INC’s filed numbers.Every claim above traces to a filing. Run any of 500+ companies through the same math-vs-mood engine. Free tier available.Open the Terminal →
Moe Alsumidaie

Moe Alsumidaie

Moe Alsumidaie, MBA, MSF, is founder and Chief Editor of Vanguard Publications, which publishes Clinical Trial Vanguard, Pharma Vanguard and BullScope, and Head of Research at CliniBiz. He has two decades in clinical trial operations and data science, with earlier roles at Genentech, Abbott Vascular and Stanford University Medical Center, and is a guest lecturer in clinical trial sciences at Rutgers University.

Recommended For You

Zoetis narrows revenue outlook as U.S. companion animal sales slide, raises profit guidance on margin strength

by Moe Alsumidaie
November 6, 2026
0

Zoetis cut its full-year revenue forecast to $9.220 billion to $9.320 billion, representing organic operational decline of 2 percent to 1 p

Read moreDetails

Viatris Raises 2026 Guidance as Adjusted EBITDA Climbs 9 Percent Year to Date

by Moe Alsumidaie
November 6, 2026
0

Viatris raised the midpoints of its full-year 2026 financial guidance across all key metrics on the strength of nine-month adjusted EBITDA

Read moreDetails

Joby Aviation raises FY26 revenue outlook 15% as eIPP flights and defense contracts accelerate path to certification

by Moe Alsumidaie
November 5, 2026
0

Joby Aviation lifted its full-year 2026 revenue guidance by 15 percent and completed the first crewed eVTOL flights under the federal gover

Read moreDetails

Amgen’s revenue growth slows to 8% as biosimilar competition erodes legacy franchises

by Moe Alsumidaie
November 4, 2026
0

Amgen's third-quarter revenue rose 8% to $10.4 billion, a deceleration from the 10.0% full-year growth rate filed for fiscal 2025. The slow

Read moreDetails

Palantir’s U.S. commercial revenue overtakes government for the first time as quarterly sales accelerate to 96% growth

by Moe Alsumidaie
November 3, 2026
0

Palantir Technologies raised full-year revenue guidance to 91% growth after U.S. commercial revenue surpassed U.S. government revenue in th

Read moreDetails
Next Post

Starbucks Comp Sales Jump 7.2% in Q4 as Pricing and Transactions Both Accelerate

Please login to join discussion
BullScope
The Research Terminal
Run any stock through the BullScope evidence engine. Filings in, evidence out. Every number explains itself.
Open the Terminal
A BullScope product

Related News

Honeywell elevates Building Automation chief to lead Process Technology as Ken West departs

August 20, 2026

Lilly’s Claims Ledger: What the Call Said, What the Filing Voted, What Held Up

August 7, 2026

Moderna raises $2.6 billion in zero-coupon convertibles as revenue collapses, betting oncology turnaround

September 3, 2026
BullScope

BullScope is an evidence-first investment research publication. Every note starts in the filings: what companies actually report, what the market assumes, and where the two disagree. We read the numbers so you can read the story. Not investment advice.

Prefer BullScope.ai on Google

© 2026 BullScope. Evidence-first investment research. Not investment advice.  ·  Methodology  ·  Privacy Policy  ·  Terms of Use  ·  Disclaimer

No Result
View All Result
  • Home
  • Market News
  • Bargains & Bubbles
  • Expectations Audits
  • Research Notes
  • Said vs. Filed
  • The Economy
  • Evidence Sheets
  • Research Terminal

© 2026 BullScope. Evidence-first investment research. Not investment advice.  ·  Methodology  ·  Privacy Policy  ·  Terms of Use  ·  Disclaimer

Not enough quota to unlock this post
Unlock left : 0
Are you sure want to cancel subscription?
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.